Eagle Pharma Outsourcing LLC recalls PHENYLephrine HCL Infusion and 1…
Eagle Pharma Outsourcing LLC recalls PHENYLephrine HCL Infusion and 1 more
- Published
- 4 Nov 2026
- Units affected
- 2 products
- Agency
- FDA
- Country
- United States
The hazard
Lack of Assurance of Sterility
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL - Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50
- Brand / company
- Eagle Pharma Outsourcing LLC
- Codes / lots
- Lot: PHENYL100-1004, Expiry: 12/31/2026. | Lot: OXY30-1006, Expiry: 10/10/2026.
- Distribution
- Nationwide within the U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.